Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
GenomePrecision
company
About
GenomePrecision is a national economic and technological development zone.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥100M
GenomePrecision has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Feb 18, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2019 | Series B | ¥100M | 2 | — | — | Detail |
| Mar 6, 2017 | Series A | — | 1 |
Sigma Square Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
GenomePrecision is funded by 2 investors.
Yizhuang Biomedical Mergers and Acquisition Funds
and Sigma Square Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
Sigma Square Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
